J Korean Ophthalmol Soc.  1987 Jun;28(3):523-529.

Treatment of Blepharospasm with Botulinum A Toxin

Affiliations
  • 1The Mt. Sinai Medical Center Cleveland, Ohio, USA.
  • 2Division of Ophthalmology Eulji Hospital, Seoul, Korea.
  • 3Division of Ophthalmology, The Mt. Sinai Medical Center, Ohio, USA.
  • 4Case Western Reserve University, USA.
  • 5Oculoplastics Clinic University, Hospitals of Cleveland, Cleveland, Ohio, USA.

Abstract

Thirty-nine patients with blepharospasm were treated with botulinum A toxin. Twenty-six patients had essential blepharospasm, and thirteen had hemifacial spasm. A total of 113 injections were given, and average follow-up was 14.6 months. The mean preinjection spasm intensity was 2.9+, and the mean post-injection spasm intensity was 0.7+. The mean interval between injections was 4.4 months. The treatment was effective, although transient, in all patients with essential blepharospasm and hemifacial spasm. The toxin had a prolonged effect on the patients who had previously undergone muscle stripping proced ure. The side effects were mild, transient, and local.


MeSH Terms

Blepharospasm*
Botulinum Toxins, Type A*
Follow-Up Studies
Hemifacial Spasm
Humans
Spasm
Botulinum Toxins, Type A
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr